Health
Biotech Leaders Discuss Future Trends
In a series of interviews, biotech leaders discussed the future of mRNA technology and AI’s role in population health. Kenneth Chien, former Moderna co-founder, predicts transformative changes with mRNA cancer vaccines. Clive Meanwell, Population Health Partners chairman, now sees AI as a catalyst for innovation.
Coverage timeline — 3 articles
STAT News
In a Q&A, Kenneth Chien, no longer with Moderna, predicts the company's mRNA cancer vaccine will be transformative for biotech.
2026-06-29 08:30 UTC
STAT News
Clive Meanwell, chairman of investment firm Population Health Partners, was an AI skeptic until recently. Now, he thinks it's a catalyst.
2026-06-29 08:30 UTC
STAT News
Portugal's National Health Service signed a deal with digital health company Sword for its AI-assisted virtual physical therapy care.
2026-06-29 08:30 UTC